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Objectives: Despite previous literature on comorbid alcohol use disorders (AUDs) in 
bipolar disorder (BD), little is known about patterns of alcohol use more widely in this 
population. We have examined lifetime heaviest average weekly alcohol consumption 
levels in a large well-characterised UK sample including lifetime clinical correlates of 
increasing levels of alcohol use. Methods: Participants were 1203 women and 673 men 
with bipolar I disorder interviewed by semi-structured interview who had consumed 
alcohol regularly at any point in their life. Results: Over half of both women (52.3%) 
and men (73.6%) had regularly consumed over double the current UK recommended 
guideline for alcohol consumption. In women and men increasing levels of lifetime 
alcohol consumption were significantly associated with presence of suicide attempts 
(women: OR 1.82, p<0.001; men: OR 1.48, p=0.005) and rapid cycling (women: OR 
1.89, p<0.001; men: OR 1.88, p<0.001). In women only, increasing levels of alcohol 
consumption were significantly associated with more episodes of depression (OR 1.35, 
p<0.001) and mania (OR 1.30, p<0.004) per illness year, less impairment in functioning 
during the worst episode of mania (OR 1.02, p<0.001), fewer psychiatric admissions 
(OR 0.51, p<0.001), comorbid panic disorder (OR 2.16, p<0.001) and eating disorder 
(OR 2.37, p<0.001). Conclusions: Our results highlight the clinical importance of 
obtaining detailed information on levels of alcohol consumption among patients with 
BD. Increased levels of alcohol use, not necessarily reaching criteria for AUD, may be 
helpful in predicting BD illness course, in particular eating disorders comorbidity in 
women.  
 






Several epidemiological studies have shown a strong association between lifetime 
alcohol use disorders (AUDs) and bipolar disorder (BD) 1–3. A number of clinical 
studies have confirmed these findings with the pooled lifetime prevalence of AUDs in 
BD calculated in a meta-analysis to be around 35% (22% and 44% in women and men 
respectively) 4. This compares to around 13% in the general population 5. There are a 
number of explanations for this association including shared genetic risk factors 6–8 and 
the self-medication hypothesis 9. 
 
The presence of AUDs in BD has been associated with a more severe and unstable 
illness course characterised by higher rates of lifetime suicide attempts 10–13, a younger 
age of onset of illness 12,13, more depressive symptoms 13, increased risk of depressive 
relapse 14  lifetime comorbid post-traumatic stress disorder (PTSD)  12,15, worse 
psychosocial functioning 13, heightened inter-episodic affective lability 16 , impulsivity 
and risk taking behaviour 17,18 and  additional substance use disorders 12,19. 
 
Despite the previous literature on comorbid AUDs in BD, little is known about the 
pattern of lifetime alcohol consumption more widely in this population and whether 
there are clinical correlates of increasing levels of alcohol use irrespective of whether or 
not the criteria for AUD are met. The limited research examining such relationships has 
mixed findings. Among 148 ‘non heavy drinkers’ with BD in Canada, increased number 
of standard drinks per week was associated with more lifetime manic episodes and more 
emergency department visits in men. Among women, increased frequency of alcohol 
use was associated with more lifetime episodes of depression and hypomania 20. In 
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contrast, in a Dutch prospective follow up study of 137 outpatients with BD, levels of 
alcohol use (defined as either no/incidental, moderate or excessive based on the average 
number of units of alcohol per week over the past 4 weeks) was not associated with 
lifetime clinical characteristics measured at baseline or any 12-month clinical course or 
outcome variables in women or men 21.  
 
Due to differences in study designs and patient populations, it is difficult to draw 
conclusions from the small number of previous studies examining the relationship 
between levels of alcohol consumption and lifetime clinical features in BD.  Further 
investigations into these relationships and patterns of alcohol consumption more 
broadly are likely to have implications for the management of BD as well as improving 
understanding of factors contributing to lifetime heterogeneity in BD illness course. In 
this study of a large and well-characterised UK sample of individuals with BD, we 
aimed firstly to describe lifetime heaviest regular alcohol consumption, and secondly to 
examine lifetime clinical correlates of increasing levels of alcohol use, including 
comorbid anxiety and eating disorders which are known to commonly co-occur with 
AUDs 22,23. Our large sample enabled us to examine these relationships in women and 
men separately, which we did in light of the findings of recent systematic reviews and 
meta-analyses which found an effect of gender on the comorbidity between AUDs and 









Data were collected as part of an ongoing UK-based programme of research into the 
genetic and non-genetic determinants of BD and related mood disorders (Bipolar 
Disorder Research Network, BDRN; bdrn.org) which has UK National Health Service 
(NHS) Research Ethics Committee approval (MREC/97/7/01) and local Research and 
Development approval in all participating NHS Trusts/Health Boards. 
 
2.1. Recruitment of participants 
Participants were recruited using both systematic and non-systematic recruitment 
methods. Systematic recruitment involved screening for potential participants through 
Community Mental Health Teams (CMHTs) and lithium clinics. Non-systematic 
recruitment included advertisements on the research team website, in local media and 
via patient support organisations (such as Bipolar UK). 
 
Participants were required to: i) be 18 years or older; ii) have mood symptoms that 
started before the age of 65 years; and, iii) be of UK white ethnicity, due to a focus on 
genetic analysis. Individuals were not eligible if they: i) experienced affective illness 
only as a result of alcohol or substance dependence; or ii) experienced affective illness 
only secondarily to medical illness or medication. 
 
Participants were interviewed using the Schedule for Clinical Assessments in 
Neuropsychiatry (SCAN) 25, which provides detailed information about lifetime 
psychopathology. Psychiatric and general practice case-notes where available were also 
reviewed. Best-estimate main lifetime diagnosis was made according to DSM-IV 
criteria and key clinical variables, such as age at illness onset, history of psychiatric 
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admissions and lifetime suicidal behaviour were rated. Level of function during each 
participant’s lifetime worst episode of depression and mania was assessed using the 
Global Assessment Scale (GAS)26 . The GAS measures overall functioning during a 
specified time-frame on a continuum from illness to health with scores ranging from 1-
100 (lowest-highest level of functioning). Information on lifetime diagnoses of other 
psychiatric illnesses was collected from participant self-report of a formal clinical 
diagnosis and from medical notes.   
 
In cases where there was doubt, diagnostic and clinical ratings were made by at least 
two members of the research team blind to each other’s rating. Inter-rater reliability was 
formally assessed using 20 cases. Mean kappa statistics were 0.85 for DSM-IV 
diagnoses and ranged between 0.81 and 0.99 for other key clinical variables; mean 
intra-class correlation coefficients were between 0.91 and 0.97 for key clinical 
continuous variables. Team members involved in the interview, rating and diagnostic 
procedures were all research psychologists or psychiatrists. 
 
2.2 Alcohol consumption 
This study was carried out on 1876 participants (1203 women and 673 men) with a 
DSM-IV main lifetime diagnosis of bipolar I disorder (BDI) who had consumed alcohol 
regularly at any point in their lifetime. Participants, who were all interviewed between 
2001 and 2013, were asked at interview how much alcohol on average they had 
consumed per week at their heaviest ever regular use which was converted into an 





2.3 Statistical analysis 
Statistical analyses were carried out using R version 3.3. Descriptive statistics were first 
carried out to describe heaviest average weekly alcohol consumption in women and 
men, including the proportion consuming over the UK weekly recommended guideline 
for alcohol consumption (14 units per week for both women and men since 2016, 21 
units for men prior to the 2016 UK guideline change). In order to examine the 
relationship between levels of alcohol consumption and lifetime clinical characteristics, 
participants were divided into five ordinal groups of equal size according their heaviest 
average regular weekly alcohol consumption (level 1 = lowest alcohol consumption to 
level 5 = highest alcohol consumption) in women and men separately.  Demographic 
and lifetime clinical characteristics were compared between groups using one-way 
analysis of variance (parametric continuous variables), Kruskal–Wallis tests (non-
parametric continuous variables) and chi-squared tests (categorical variables).  
 
Ordinal regression models were then used to analyse the relationship between levels of 
alcohol consumption and each clinical characteristic significant at p<0.05 in the 
univariate analyses.  Each characteristic was examined separately adjusting for potential 
confounding demographic variables found to be significantly associated with the levels 
of heaviest average regular weekly alcohol consumption among women and men in the 
sample respectively. The proportional odds assumption for the ordinal regression 
models were met, which justified the calculation of a single adjusted odds ratio for each 







The distribution and patterns of heaviest average regular weekly alcohol consumption 
among women and men with BD who had consumed alcohol regularly at any point in 
their lifetime are presented in Table 1 and Figure 1. The median heaviest average 
weekly units of alcohol consumed was 30 in women and 50 in men. Heaviest average 
regular weekly alcohol consumption was in excess of the current UK weekly 
recommended guideline among 71% of women and 88% of men, and was at least twice 
over the recommended guideline (30 units or more per week) among 52% and 74% of 
women and men respectively. 79% of men had consumed over the previously higher 
recommended UK guideline of 21 units per week which were in place at the time of 
data collection, with 55% of men consuming over twice the previous recommended 
guideline (45 units or more per week). 
 
Relationships between levels of heaviest regular alcohol consumption and lifetime 
clinical characteristics in women and men are shown in Tables 2 and 3 respectively. 
Within women, after controlling for potential demographic confounders (age at 
interview and level of education) odds of increasing levels of alcohol consumption were 
significantly associated with having a younger age of illness onset (OR 0.97, 95% CI 
0.95-0.98, p<0.001), history of rapid cycling (OR 1.89, 95% CI 1.45-2.47, p<0.001), 
more episodes of depression per illness year (OR 1.35, 95% CI 1.16-1.58), p<0.001), 
more episodes of mania per illness year (OR 1.30, 95% CI 1.10-1.58, p<0.004), less 
impairment in functioning during the worst episode of mania (OR 1.02, 95% CI 1.01-
1.03), p<0.001), history of suicide attempts (OR 1.82, 95% CI 1.48-2.26, p<0.001), 
fewer psychiatric admissions (OR 0.51, 95% CI 0.38-0.67, p<0.001), and history of 
panic disorder (OR 2.16, 95% CI 1.61-2.91, p<0.001) and eating disorder (OR 2.37, 
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95% CI 1.64-3.44, p<0.001). In men, after controlling for age at interview, increasing 
levels of alcohol consumption were significantly associated with history of rapid 
cycling (OR 1.88, 95% CI 1.30-2.72, p<0.001) and suicide attempts (OR 1.48, 95% CI 
1.12-1.96, p= 0.005). A trend was however observed for increasing levels of alcohol 
consumption to be associated with a younger age of illness onset and history of panic 
disorders in men with stratified group sizes for eating disorder history being too small 
for statistical analysis. 
 
4. Discussion 
This is the first study to examine patterns and clinical correlates of increasing levels of 
lifetime alcohol consumption among individuals with BD in a large UK sample. Among 
both women and men a large proportion of the sample who had consumed alcohol 
regularly at any point in their life had, at their heaviest, regularly consumed over the 
recommended UK guideline at the time for alcohol consumption. In fact approximately 
half of both women and men had consumed over double the recommend guideline. This 
figure is increased in men when considering the new UK guideline in place since 2016 
which lowered the recommend weekly units of alcohol consumption for men from 21 to 
14 in line with the guideline for women. While there are no directly comparable general 
population lifetime figures available, these high proportions further highlight the 
importance of routinely screening for level of alcohol use among individuals with BD. 
In the UK at least, rates of recording alcohol consumption in primary care among adults 
with BD are high 27. However, the extent to which effective interventions are 




Our results extend previous research which has predominantly focused on correlates of 
lifetime AUDs in BD and not considered levels of lifetime alcohol consumption more 
broadly. We did find differences between women and men which is in keeping with 
previous research that has found gender-specific differences in clinical correlates of 
lifetime AUDs in BD 15,28. Although different gender-specific patterns were observed, 
among both women and men markers of a more severe and unstable BD illness course 
(rapid cycling and suicidal attempts) were associated with increasing levels of alcohol 
consumption. Despite this, increasing levels of alcohol consumption were not found to 
be associated with number of admissions in men and were associated with fewer 
psychiatric admissions in women. These findings are surprising given the high rates of 
history of suicide attempts among individuals in the highest level of heaviest average 
regular alcohol consumption (74% in women and 54% in men). However they do 
support results from a previous study that found that despite a more frequent history of 
suicidal behaviours, those with comorbid BD and AUDs were no more likely to receive 
any more, or more intensive, treatment than those without 10. Increasing levels of 
alcohol consumption in women were significantly associated with less impairment in 
functioning during the worst episode of mania which may in part explain our finding of 
fewer psychiatric admissions. In contrast, impairment during the worst episode of 
depression was not significantly associated with increasing levels of alcohol 
consumption. Unfortunately, we were unable to stratify hospital admissions into those 
for the treatment of depression and mania which may have revealed different patterns. 
Interestingly our results are in contrast to the previous finding in a prospective Dutch 
study that found levels of alcohol use, assessed over the past four weeks, were not 
associated with a number of  baseline lifetime clinical characteristics of BD including 
history of suicide attempts 21. However, the studies are not directly comparable due to 
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the different timeframes used (lifetime compared to past four weeks) and different 
methods of categorising levels of alcohol consumption based on average weekly units. 
 
Among women in our sample, increasing levels of heaviest average regular weekly 
alcohol consumption were additionally significantly associated with a younger age of 
illness onset and self-reported formal clinical diagnosis of panic disorder and eating 
disorder. Among these disorders, differing patterns were observed with increasing 
levels of alcohol consumption. Prevalence of eating disorder comorbidity increased 
more steadily across the levels of alcohol consumption compared to panic disorder 
comorbidity which was notably more prevalent at higher levels of alcohol consumption. 
Although lifetime AUDs have been found to be associated with panic disorder in 
general population epidemiological studies 29, previous studies have not found this 
association specifically in BD samples 12,15. The presence of a lifetime anorexia nervosa 
diagnosis has previously been found to be significantly associated with AUD in 
univariate analyses in a BD sample 12. However due to small stratified group sizes the 
association did not remain significant in multivariate analyses and was not examined 
separately in women and men. The relationship between alcohol consumption and 
specific eating disorder comorbidities warrants investigation in further larger samples of 
women with BD.  
 
Due to the cross-sectional study design we are unable to comment on the causal 
direction of the relationship between alcohol consumption levels and lifetime clinical 
characteristics of BD in our sample.  Prospective studies, in particular focusing on 
levels of alcohol consumption in women and the relationship with anxiety symptoms 
are required. Furthermore, we did not collect data on family history of AUD or drinking 
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patterns including the onset of alcohol use in relation to the onset of BD and the lifetime 
frequency or duration of periods of alcohol consumption, which would be important 
factors to measure in future studies in both BDI and BDII. Our sample also does not 
reflect the gender distribution of BD in the general population. 30 This is due to female 
volunteer bias in our wider BDRN research programme and a result of our use non-
systematic, in addition to systematic, recruitment methods. An additional limitation is 
that were unable to explore the relationship between increasing levels of alcohol use and 
other medical and psychiatric comorbidities that have been found to co-occur with 
AUDs, for example, post-traumatic stress disorder.  
 
In addition to highlighting patterns of lifetime alcohol consumption in a large sample of 
individuals with BD, our findings suggest obtaining information about both current and 
past levels of alcohol consumption, particularly in women, may be helpful in identifying 
eating disorders comorbidity. Our results also highlight the importance of collecting 
quantifiable data on amount of alcohol consumption in future BD samples, particularly 
in those intended for international consortium collaborations where guidelines both 
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Table 1 Heaviest average regular weekly units of alcohol consumed in women and men with bipolar I disorder who had consumed alcohol regularly 
at any point in their lifetime 
 
 
 Women (n=1203) Men (n=673) 
Median (IQR) 
 
30 (48) 50 (72) 
Mean (SD) 
 




Heaviest average regular consumption over 
current UK weekly recommended guideline † , % 
(n) 
70.6 (849) 87.8 (591) 
Heaviest average regular consumption over UK 
weekly recommended guideline prior to change 
for men in 2016 ‡, % (n) 
- 79.2 (533) 

















Table 2 Comparison of lifetime demographic and clinical characteristics according to levels of heaviest average regular weekly alcohol consumption 
in women 
 Alcohol consumption    











 p-value  
Adjusted 
OR ‡ (95% CI), p-value 
Heaviest average regular alcohol units/week 
consumed: median (range) 
5 (1-9) 14 (10-20) 30 (21-39) 50 (40-70) 112 (75-800) - - 
Demographic variables          
Age at interview, years: mean (SD) 49.5 (12.0) 45.8 (11.3) 43.8 (12.0) 43.8 (11.6) 43.7 (10.1) <0.001 - 
Completed higher education n (%) 65 (30.5) 
 
122 (49.0) 94 (43.7) 136 (51.1) 80 (36.7%) <0.001 - 
Has never married / never lived as married n 
(%) 
19 (8.7) 37 (15.0) 33 (15.4) 32 (12.0) 29 (13.4%) 0.215 - 
Systematically recruited n (%) 
 
70 (31.7) 65 (25.6) 47 (22.0) 75 (27.3) 62 (27.7) 0.237 - 
Lifetime clinical characteristics         
Age at illness onset, years: median (IQR) 
range 
23.5 (11) 9-56 21 (12) 4-59   20 (10) 7-55 18 (10) 4-58 18 (7) 7-51 <0.001 0.97 (0.95-0.98), <0.001 
 
Rapid cycling present n (%) 39 (23.9) 50 (27.2) 43(26.5) 77 (40.7) 78 (51.0) <0.001 1.89 (1.45-2.47), <0.001 
 
No. episodes depression per illness year: 












<0.001 1.35 (1.16-1.58), <0.001 













<0.001 1.30 (1.10-1.58), 0.004 













<0.001 1.00 (0.99-1.01), 0.688 













<0.001 1.02 (1.01-1.03), <0.001 




Psychiatric admission n (%) 207 (95.4) 223 (88.1) 187 (86.2) 210 (76.9) 181 (80.8) <0.001 0.51 (0.38-0.67), <0.001 
 
Psychotic symptoms present n (%) 
 
157 (77.3) 194 (84.7) 149 (77.2) 179 (79.2) 140 (74.5) 0.112 - 
Family history of bipolar disorder n (%) 
 
26 (13.1) 11 (5.3) 26 (14.3) 29 (12.1) 20 (10.2) 0.035 1.12 (0.79-1.61), 0.520 
Panic disorder present n (%) 19 (17.8) 24 (13.6) 30 (19.1) 59 (27.6) 63 (34.4) <0.001 2.16 (1.61-2.91), <0.001 
 
Eating disorder † present n (%) 5 (4.7) 8 (4.4) 24 (14.4) 32(14.4) 40 (21.2) <0.001 2.37 (1.64-3.44), <0.001 
 
IQR= inter quartile range, OR=odds ratio, CI= confidence interval, GAS=Global Assessment Scale. Totals vary due to unknown/missing data.  Bolded values are statistically significant 
























Table 3 Comparison of lifetime demographic and clinical characteristics according to levels of heaviest average regular weekly alcohol consumption 
in men 
 Alcohol consumption level   











 p-value  
Adjusted 
OR ‡ (95% CI), p-value 
Heaviest average regular alcohol units/week 
















Demographic variables          
Age at interview, years: mean (SD) 50.3 (13.0) 47.9 (11.9) 46.6 (11.5) 47.5 (11.8) 46.6 (11.0) 0.033 - 
Completed higher education n (%) 52 (41.9) 66 (45.2) 49 (41.9) 54 (41.5) 49 (40.5) 0.950 - 
Has never married / never lived as married n 
(%) 
32 (25.2) 32(22.1) 19(16.7) 30(23.8) 21(17.9) 0.417 - 
Systematically recruited n (%) 
 
51(38.9) 49(32.2) 45(37.2) 48(35.3) 40(32.8) 0.753 - 
Lifetime clinical characteristics        
Age at illness onset, years: median (IQR) 
range 
23.5 (17) 10-54 22 (12) 7-58 21 (12) 9-63 22.5 (13) 12-53 21 (11) 7-47 0.083 - 
Rapid cycling present n (%) 16 (17.0) 26 (24.5) 23 (25.3) 24 (23.8) 41(44.1) 0.001 1.88 (1.30-2.72), <0.001 
 
No. episodes depression per illness year: 












<0.001 1.10 (0.98-1.28), 0.126 
No. episodes (hypo) mania per illness year: 





































30   
10-50) 
0.153 - 




Psychiatric admission n (%) 
 
113(86.9) 141(91.0) 100(84.0) 119(86.9) 105(84.7) 0.455 - 
Psychotic symptoms present n (%) 86(73.5) 
 
104(76.5) 80(74.1) 85(72.6) 77(74.0) 
 
0.969 - 
Family history of bipolar disorder n (%) 
 
11 (9.5) 10 (7.9) 7 (6.9) 15 (14.0) 11 (10.3) 0.440 - 
Panic disorder present n (%) 
 
9(10.8) 19(17.6) 7(8.1) 14(15.9) 20(21.1) 0.105 - 
Eating disorder † present n (%) 0 (0.0) 2 (1.9) 2 (2.2) 1 (1.1) 4 (4.2) § - 
IQR= inter quartile range, OR=odds ratio, CI= confidence interval, GAS=Global Assessment Scale. Totals vary due to unknown/missing data.  Bolded values are statistically significant 






Figure 1 Proportions and distribution of heaviest average regular weekly units of alcohol 
consumed in women (n=1203) and men (n=673) with bipolar I disorder who had consumed 
alcohol regularly at any point in their lifetime 
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